GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nanobiotix NANO.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

28.50

+5.56%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

12 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 4Strong buy
  • 7Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Last close 28.50Average target 23.32

Low
19.90
Average
23.32
Median
22.95
High
29.40

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue€25.9m€61.8m€95.0m€88.0m€146.5m
Revenue, highest€43.1m€168.8m€230.7m€207.0m€344.6m
Revenue, lowest€8.8m€3.3m€2.3m€10.0m€16.6m
Earnings per share-0.54-0.200.450.180.94
Earnings per share, highest-0.310.531.720.492.60
Earnings per share, lowest-0.91-0.78-0.63-0.03-0.14
Analysts66643

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q1 2026Q3 2025Q2 2025Q4 2024Q3 2024Q2 2024Q1 2024
Forecast-0.420.26-0.21-0.32-0.55-0.21-0.21-0.75
Reported-0.70-0.39-0.11-0.11-0.98-0.46-0.46-0.29
Difference-66.6%-251.0%+47.6%+65.2%-79.6%-119.0%-120.0%+61.3%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 22.1% a year over 10 years. Return on equity 28.4%.

Model fair value

26.07

From earnings —, from revenue 26.07.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.